Supplémentation en vitamine D et Covid-19 : consensus d’experts et recommandations (notice n° 647539)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03220cam a2200301 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250121183554.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Annweiler, Cédric |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Supplémentation en vitamine D et Covid-19 : consensus d’experts et recommandations |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2021.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 79 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Après 12 mois de circulation virale, le SARS-CoV-2 a infecté des millions de personnes dans le monde, faisant des centaines de milliers de morts. En l’absence de traitement curatif, préventif ou vaccinal efficace et accessible à ce jour contre le Covid-19, recourir à des médicaments déjà existants pourrait aider à enrayer la pandémie. La vitamine D est un candidat possible discuté dans de nombreuses publications. Des essais cliniques randomisés montrent que la supplémentation en vitamine D réduit significativement le risque d’infections respiratoires. Il existe également de nombreux arguments suggérant que l’hypovitaminose D constitue un facteur de risque indépendant (et facilement modifiable) des formes graves de Covid-19 et de mortalité par Covid-19. La supplémentation en vitamine D est une mesure simple, sans risque, peu coûteuse et remboursée par l’assurance maladie, qui est efficace pour corriger l’hypovitaminose D retrouvée chez 40 à 50 % de la population française et chez plus de 80 % des adultes atteints de Covid-19. Dans ce papier de position, nous proposons des schémas simples de supplémentation vitaminique D chez l’adulte en l’absence ou en cas de Covid-19. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | After 12 months of viral circulation, the SARS-CoV-2 has infected millions of people around the world, leaving hundreds of thousands dead. With the lack of effective therapy and vaccination against COVID-19, focusing on the immediate repurposing of existing drugs gives hope of curbing the pandemic. Vitamin D is a possible candidate discussed in a high amount of publications. Randomized clinical trials show that vitamin D supplementation significantly reduces the risk of respiratory infections. There are also many evidences that hypovitaminosis D is an independent (and easily modifiable) risk factor for severe forms of COVID-19 and death. Vitamin D supplementation is a simple, safe and inexpensive measure, which is effective in correcting hypovitaminosis D found in 40-50% of the French population and in more than 80% of adults with COVID-19. In this position paper, we propose simple regimens (adapted to the pharmaceutical forms currently available in France) for vitamin D supplementation in adults with or without COVID-19. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | supplémentation |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | vitamine D |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | SARS-Cov-2 |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Covid-19 |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | recommandations |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | vitamin D |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | COVID-19 |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | supplementation |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | SARS-CoV-2 |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | guidelines |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Souberbielle, Jean-Claude |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Gériatrie et Psychologie Neuropsychiatrie du Vieillissement | 19 | 1 | 2021-03-01 | p. 20-29 | 2115-8789 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-geriatrie-et-psychologie-neuropsychiatrie-du-vieillissement-2021-1-page-20?lang=fr&redirect-ssocas=7080">https://shs.cairn.info/revue-geriatrie-et-psychologie-neuropsychiatrie-du-vieillissement-2021-1-page-20?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux